Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Disorders”

21,872 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21,872 results

Testing effectiveness (Phase 2)WithdrawnNCT05170789
What this trial is testing

Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Tulane University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT04269889
What this trial is testing

Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag

Who this might be right for
Anemia, Diamond-Blackfan
National Heart, Lung, and Blood Institute (NHLBI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT06561360
What this trial is testing

Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)

Who this might be right for
Hairy Cell Leukemia
Memorial Sloan Kettering Cancer Center 86
Large-scale testing (Phase 3)Not Yet RecruitingNCT07193420
What this trial is testing

Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
GVHD - Graft-Versus-Host DiseaseHSCTHaploidentical Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 180
Post-approval studies (Phase 4)Study completedNCT03598582
What this trial is testing

Biological Predictive Factors of Response to ESA in Low Risk MDS Patients

Who this might be right for
Myelodysplastic Syndromes
Association pour la recherche sur les Affections Malignes en Immunologie Sanguine 70
Large-scale testing (Phase 3)Study completedNCT01788020
What this trial is testing

Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
University of Ulm 202
Testing effectiveness (Phase 2)Ended earlyNCT01023880
What this trial is testing

Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy

Who this might be right for
Multiple Myeloma
Cephalon 62
Early research (Phase 1)Study completedNCT00076180
What this trial is testing

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic LeukemiaLeukemia, T-Cell Large Granular Lymphocytic
National Cancer Institute (NCI) 9
Early research (Phase 1)Not Yet RecruitingNCT07113496
What this trial is testing

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Who this might be right for
Relapsed or Refractory B-cell Hematologic MalignanciesB-cell Acute Lymphoblastic Leukemia (B-ALL)Multiple Myeloma (MM)+3 more
The First Affiliated Hospital with Nanjing Medical University 27
Early research (Phase 1)Looking for participantsNCT02203903
What this trial is testing

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Who this might be right for
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
Catherine Bollard 50
Post-approval studies (Phase 4)UnknownNCT02576327
What this trial is testing

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Vomiting
Jun Zhu 130
Testing effectiveness (Phase 2)Study completedNCT00511069
What this trial is testing

Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia

Who this might be right for
Leukemia
University of Bologna 3
Not applicableStudy completedNCT01446783
What this trial is testing

IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients

Who this might be right for
Ehlers-Danlos Syndrome, Classic
Bispebjerg Hospital 15
Not applicableStudy completedNCT04506125
What this trial is testing

Liberal Versus Restrictive Transfusion Threshold in Oncologic surgerY

Who this might be right for
Oncologic ComplicationsAnemia
University Hospital, Brest 30
Large-scale testing (Phase 3)Study completedNCT00784017
What this trial is testing

Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukemia
medac GmbH 199
Early research (Phase 1)Study completedNCT02193191
What this trial is testing

Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00551291
What this trial is testing

NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.

Who this might be right for
Myelodysplastic Syndromes
Hoffmann-La Roche 10
Not applicableEnded earlyNCT01761682
What this trial is testing

Acute Lymphoblastic Leukemia Registry at Asan Medical Center

Who this might be right for
Leukemia, Acute LymphoblasticPrecursor B-Cell Lymphoblastic LeukemiaLeukemia, Biphenotypic, Acute+2 more
Asan Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT02139280
What this trial is testing

Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy

Who this might be right for
Hematologic Malignancies
Dartmouth-Hitchcock Medical Center 58
Large-scale testing (Phase 3)Study completedNCT00546780
What this trial is testing

Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 31
Load More Results